|Bid||1.610 x 0|
|Ask||1.640 x 0|
|Day's Range||1.600 - 1.640|
|52 Week Range||1.240 - 2.010|
|PE Ratio (TTM)||12.30|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.35|
Aug 29 (Reuters) - PW Medtech Group Ltd: * HY PROFIT ATTRIBUTABLE RMB1,587.8 MILLION VERSUS RMB81.7 MILLION * HY REVENUE FROM CONTINUING OPERATIONS RMB143.0 MILLION, UP 9.8% Source text for Eikon: Further ...
Aug 24 (Reuters) - PW Medtech Group Ltd: * CO TO PURCHASE 800,000 CHINA BIOLOGIC PRODUCTS (CBPO) SHARES, AT A PRICE OF US$100.9 PER CBPO SHARE * AGGREGATE PURCHASE PRICE FOR CBPO SHARES SHALL BE $80.72 ...
When PW Medtech Group Limited (HKG:1358) announced its most recent earnings (31 December 2017), I compared it against two factor: its historical earnings track record, and the performance of itsRead More...
Robust, high-growth companies such as MicroPort Scientific are appealing to investors for many reasons. They bring about a strong upside to your portfolio, and less downside risk as opposed toRead More...
Robust, high-growth companies such as Goodbaby International Holdings are appealing to investors for many reasons. They bring about a strong upside to your portfolio, and less downside risk as opposedRead More...
Regina Miracle International (Holdings) and Tian Ge Interactive Holdings are a few noticeable companies with a strong future outlook. The market’s optimistic sentiment towards these stocks indicates a level ofRead More...
BEIJING , Jan. 3, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ( "CBPO" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company ...
Categories: Yahoo FinancePW Medtech Group Ltd. relative valuation is OVERVALUED and it has a fundamental analysis score of 41. Our analysis is based on comparing PW Medtech Group Ltd. with the following peers – Shandong Weigao Group Medical Polymer Co. Ltd. Class H, Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H and LifeTech Scientific Corporation (1066-HK, 1858-HK ... Read more (Read more...)